Artesian Resources is recommended as a buy due to its strong infrastructure investments and a favorable rate case with Delaware regulators. The stock trades at a 22% discount to its fair value, with a forward price-to-earnings ratio of 15.5 compared to a justified 20, indicating potential upside. Although earnings per share may face temporary challenges in 2026, a 10% rebound is expected in 2027 as new assets begin generating regulated returns. The company also offers a 4% forward dividend yield, a low payout ratio, and has a 29-year streak of dividend growth, highlighting its reliability and potential for continued income growth.
The phase III ENDURANCE trial showed that two years of lenalidomide maintenance therapy offers the same long-term survival benefit as indefinite treatment for patients with standard-risk multiple myeloma who are not transplant candidates. After nearl...
Trupanion, a pet insurance provider, operates in the growing pet care market with subscription plans for cats and dogs. Despite a recent 2.68% dip, the stock has gained 4.13% over 30 days, indicating positive momentum and a potential buying opportuni...
Cass Information Systems reported strong first-quarter earnings of $0.66 per share, beating estimates, and achieved record annual net income of $35.1 million. The company is improving operational efficiency through automation and workforce reductions...
Piper Sandler raised its price target for UnitedHealth Group to $475, suggesting a 13.3% upside from its current price of $419.23. The company, the largest U.S. health insurer, has consistently beaten earnings estimates, with its latest EPS of $7.23 ...
Citigroup lowered its price target for Ericsson to SEK 105 from SEK 110 and kept a Neutral rating after the company's Q2 2026 results missed revenue and earnings estimates. Ericsson's shares dropped over 13% due to rising component costs, especially ...
